Together we are beating cancer

Donate now

Bladder cancer

Showing 12 out of 47 results
A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022

An empty hospital corridor

A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer

by Jacob Smith | News | 26 May 2022

26 May 2022

Medical technologist holding urine tube test in medical laboratory

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

by Lilly Matson | Analysis | 16 April 2022

16 April 2022

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible. A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

by Harry Jenkins | Analysis | 14 July 2021

14 July 2021

doctor holding urine sample

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures. The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

by Harry Jenkins | News | 2 July 2021

2 July 2021

A

We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier. We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier.

by Gabriella Beer | Analysis | 21 November 2019

21 November 2019

This entry is part 2 of 4 in the series Detecting cancer early

Women with bladder or kidney cancer may lose out on a prompt diagnosis if they are already being regularly treated for recurring urinary tract infections (UTIs) Women with bladder or kidney cancer may lose out on a prompt diagnosis if they are already being regularly treated for recurring urinary tract infections (UTIs)

by Cancer Research UK | News | 13 February 2019

13 February 2019

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.

by Cancer Research UK | News | 2 January 2019

2 January 2019

Zarah Harrison

Following the publication of a new piece of cancer research, one of our colleagues reflects on the contribution his late fiancee made in making it happen. Following the publication of a new piece of cancer research, one of our colleagues reflects on the contribution his late fiancee made in making it happen.

by Henry Scowcroft | Analysis | 28 September 2018

28 September 2018